MYND Life Sciences Inc
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
$1.7M
-0.03
MYND Life Sciences, Inc. is a neuro-pharmaceutical drug development company. The firm is focused on neuro-pharmaceutical and novel psilocybin drug development, and diagnostics. The firm is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by molecular concepts for the applications of Psilocybins for overcoming disease. The firm is engaged in pharmaceutical developments through rigorous science and clinical trials while diligently patenting and safeguarding its intellectual property.
MYND Life Sciences, Inc. is a neuro-pharmaceutical drug development company. The firm is focused on neuro-pharmaceutical and novel psilocybin drug development, and diagnostics. The firm is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by molecular concepts for the applications of Psilocybins for overcoming disease. The firm is engaged in pharmaceutical developments through rigorous science and clinical trials while diligently patenting and safeguarding its intellectual property.
Recently from Cashu
Couldn't load Cashu news
Something went wrong. Try refreshing the page.